Title : A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro.

Pub. Date : 2016

PMID : 27340679






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The detoxified TLR4-ligand Monophosphoryl Lipid A (MPLA) is the first approved TLR-agonist used as adjuvant in licensed vaccines but has not yet been explored as part of conjugated vaccines. Lipid A toll like receptor 4 Homo sapiens